Literature DB >> 9358649

Plakinidine D, a new pyrroloacridine alkaloid from the ascidian Didemnum rubeum.

P W Ford1, B S Davidson.   

Abstract

Plakinidine D (4), a new pyrroloacridine metabolite, was isolated together with the known compound 3,5-diiodo-4-methoxyphenethylamine (5) from the ascidian Didemnum rubeum collected near the island of Rota, Northern Mariana Islands. Spectroscopic methods were used to determine the structure of plakinidine D, which was also confirmed through the formation and characterization of the derivatives N-acetylplakinidine D and 11-deoxyplakinidine D. Plakinidine D represents the first metabolite in the pyrroloacridine family of compounds to be isolated from an ascidian.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358649     DOI: 10.1021/np970312o

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

1.  Pyrroloacridine alkaloids from Plakortis quasiamphiaster: structures and bioactivity.

Authors:  Paul Ralifo; Laura Sanchez; Nadine C Gassner; Karen Tenney; R Scott Lokey; Theodore R Holman; Frederick A Valeriote; Phillip Crews
Journal:  J Nat Prod       Date:  2007-01       Impact factor: 4.050

2.  Toward the Total Synthesis of Alpkinidine: Synthesis of Haloquinone CE Ring System Synthons and Attempted Nucleophilic Bisannulation.

Authors:  Marco Buccini; Louisa Tham; Francis Dhoro; Brian W Skelton; Craig M Williams; Matthew J Piggott
Journal:  ACS Omega       Date:  2022-06-01

3.  Amino Acid-Derived Metabolites from the Ascidian Aplidium sp.

Authors:  Tae Hyung Won; Chang-Kwon Kim; So-Hyoung Lee; Boon Jo Rho; Sang Kook Lee; Dong-Chan Oh; Ki-Bong Oh; Jongheon Shin
Journal:  Mar Drugs       Date:  2015-06-16       Impact factor: 5.118

Review 4.  Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.

Authors:  Satheesh Kumar Palanisamy; N M Rajendran; Angela Marino
Journal:  Nat Prod Bioprospect       Date:  2017-01-17

Review 5.  Secondary Metabolites of the Genus Didemnum: A Comprehensive Review of Chemical Diversity and Pharmacological Properties.

Authors:  Diaa T A Youssef; Hadeel Almagthali; Lamiaa A Shaala; Eric W Schmidt
Journal:  Mar Drugs       Date:  2020-06-11       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.